The unit, in Craigavon, Northern Ireland, will produce ‘regional’ packs for European markets that share a common language, which will offer significant benefits according to Almac distribution manager Mark English.
“Grouping countries by language allowing for multi-language packs to service multiple markets, with country specific information added at point of despatch, provides significant cost advantages.
He added that: “Working with products that are manufactured in very low volumes at, often, a very high cost means that solutions to minimise stock holding are of particular benefit.”
Almac's investment is timely given that, increasingly drugmakers are focused on developing niche, high-value pharmaceutical products, the correct storage and appropriate distribution of which is critical.